Suresh S. Ramalingam, MD, FASCO @RamalingamMD Twitter profile

Last Seen Profiles

@allison_lm

@stw46

@easternplaybook

@bokeplokalmalam

@haznun1

@ronckk

@donotbesoweird

@sara69785650

@buayamerah14

@MikeySpumoni

@ygorxflp

@TotalShemaleAdd

@BodeUlpts

@oRealSniper

@ballocks_MCfall

@Black_Sherry013

@SenkouRabbit

@capriccio_lndna

@deci_johnyyS

@V3Cyclone

@HiremathTnie

@paulwdiggory

@BinkerGolding

@DeniSetiab16267

@ftsocan

@freelancerguy_

@stwmaniax

@jujutsu_cos

@mero_chiyono

@DeniSetiab16267

@bokeplokalmalam

@maofth

@abhishekshah

@KremlinRussia_E

@ygorxflp

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Celebrating the new paper in ⁦ @CellCellPress ⁩ with a cake… literally! ⁦ @WinshipAtEmory ⁩ ⁦ @HaianFu ⁩ ⁦ @weibzhou ⁩ ⁦ @EmoryUniversity ⁩.

24

44

1K

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

I am incredibly honored and excited to be appointed as the Executive Director of @WinshipAtEmory . Very thankful to my family, friends, mentors and colleagues who have provided guidance & support over the years.

Winship Cancer Institute of Emory University

@WinshipAtEmory

3 years

Internationally renowned thoracic oncologist and physician scientist, Suresh S. Ramalingam, MD, has been named Winship's executive director. He begins his new post July 1. Congratulations @RamalingamMD , we're thrilled to have you at the helm! ➡️

22

18

160

70

27

360

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Happy to share the FLAURA study OS results; just published in @NEJM @WinshipAtEmory @EmoryMedicine @emoryhealthcare #LCSM .

12

84

286

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Osimertinib is the first TKI to improve OS over another TKI across the entire Oncology landscape! #ESMO19 @AstraZeneca @WinshipAtEmory #LCSM . Honored to lead this study and present the data!

20

66

271

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

I am honored and excited! Thanks to @DrFadloKhuri for his outstanding leadership of the journal for the past 10 years. @JournalCancer @WinshipAtEmory @ACSNews @EmoryMedicine

ACS Journal Cancer

@JournalCancer

4 years

📢We are very pleased to announce Suresh S. Ramalingam, MD ( @RamalingamMD ) as our new Editor-in-Chief beginning July 2021. Dr. Ramalingam is currently Deputy Director @WinshipAtEmory and Chest & Lung Disease Section Editor of Cancer. Please join us in welcoming Dr. Ramalingam!👏

6

25

141

39

19

238

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

With FDA approval of #sotorasib there are 9 targets with proven therapies in #NSCLC . Let us make sure that every patient gets NGS testing at diagnosis. @WinshipAtEmory @IASLC #LCSM @ASCO

5

48

224

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Excited to welcome ⁦ @reshmajagsi ⁩ on her first day at ⁦ @WinshipAtEmory ⁩ ⁦ @EmoryMedicine ⁩ as chair of Rad Onc.⁦ @EmoryUniversity ⁩ ⁦ @emoryhealthcare ⁩ ⁦ @NRGonc ⁩

4

11

171

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Can we ask the insurance companies to place a temporary freeze on peer-to-peer requests during this crisis? I did three of them this week! @ASCO @mtmdphd @VincentRK @drdonsdizon @montypal @drgandara @HwakeleeMD @LeciaSequist @HosseinBorghaei @IASLC @teekayowo @wallyjc

11

34

159

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Excited to welcome @reshmajagsi as the next chair of Radiation Oncology at @EmoryMedicine @WinshipAtEmory . @ASCO @NRGonc @SWOG @theNCI .

Winship Cancer Institute of Emory University

@WinshipAtEmory

2 years

Internationally recognized breast cancer and bioethics researcher and radiation oncologist, Reshma Jagsi, MD, DPhil, will join @EmoryMedicine and Winship as chair of the Department of Radiation Oncology, effective Nov. 7, 2022. #RadOnc ➡️

50

44

496

9

10

158

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Thanks to @ASCO for this wonderful recognition. #ASC019 @WinshipAtEmory

Winship Cancer Institute of Emory University

@WinshipAtEmory

5 years

Congratulations ⁦ @RamalingamMD ⁩ for being honored as a FASCO, Fellow of the American Society of Clinical Oncology, #ASCO19 for you commitment, dedication and service.

2

7

47

23

12

154

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

From my photo archives- will cherish this one as we mourn the loss of Rep. John Lewis, a hero by every definition of the word. The nation has lost one of its great sons.

1

10

142

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Another exciting presentation on immunotherapy at #ESMO2019 and a NEJM paper to go with it. #LCSM . more good news for patients. @WinshipAtEmory @EmoryMedicine @bmsnews

4

42

128

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

I voted in-person today, the first day of early voting in Georgia for racial justice, a science- driven society and restoration of decency. Thanks to @emoryhealthcare for providing time off to #vote .

0

6

127

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

CT screening reduces lung cancer mortality by 39% in women and 24% in men. Let us ensure that every at risk individual is screened. @IASLC #wclc2018 @WinshipAtEmory #LCSM

3

63

123

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 months

Great to have @LealTiciana lead @WinshipAtEmory lung program to the next level! Congrats!

Winship Cancer Institute of Emory University

@WinshipAtEmory

5 months

Congrats to Ticiana Leal, MD, who has been named the new leader of the Lung Cancer Disease Team at Winship, effective immediately. Dr. Leal will lead the multidisciplinary disease team in advancing clinical, translational and catchment-area priorities for lung cancer.

1

2

38

18

9

122

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Even as we celebrate research success at #ASCO20 , it is hard not to shed tears for the injustice that happen(s)ed around us this week. I take the knee locking hands with ⁦ @Kaepernick7 ⁩ today. What about you?

6

13

113

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Congrats to my friend and colleague @HwakeleeMD for her appointment as the Deputy Director of @StanfordCancer and Director of Medical Oncology. @Stanford . Well done! @WinshipAtEmory @IASLC #LCSM

13

2

114

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

It has been an incredible honor to serve as the @eaonc Thoracic Committee chair for the past 10 years. Delighted to pass the torch to @JulieBrahmer and @HosseinBorghaei . Please join me in congratulating them. @HwakeleeMD @WinshipAtEmory @EmoryMedicine

8

10

108

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Wonderful to run into ⁦ @DrSanjayPopat ⁩ at the #ICC Cricket World Cup at the London Oval. Team India had a magnificent innings with the bat. Thinking of our Aussie friends Ben Solomon, Mike Boyer. ⁦ @WinshipAtEmory ⁩

11

3

107

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

Very proud of my @WinshipAtEmory colleagues whose dedication and commitment brings us closer to achieving our mission of discovering cures for cancer and inspiring hope with every passing day! @theNCI @WinshipAtEmory

Winship Cancer Institute of Emory University

@WinshipAtEmory

1 year

We're proud to have received renewal of the prestigious #ComprehensiveCancerCenter designation from @theNCI , ensuring our continuing place in the top tier of U.S. cancer centers. Learn what it means for patients with cancer in GA: .

2

5

46

6

8

98

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

Our amazing new ⁦ @WinshipAtEmory ⁩ Midtown set to inaugurate today! Research- driven multidisciplinary patient-centered cancer care- ‘The Winship Way’! Thanks to so many who have made this a reality. ⁦ @EmoryUniversity ⁩ ⁦ @emoryhealthcare ⁩

6

13

91

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

Great to be at the Capitol Hill with ⁦ @KFKerstannPhD ⁩ to advocate for cancer research funding. #AACIOnTheHill #AACROnTheHill #FundNIH #FundNCI ⁦ @WinshipAtEmory ⁩

3

9

92

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 months

Grateful for the support from @ConquerCancerFd in 2006 CDA, a game changer for my career development. That award was to conduct research on targeted therapies for lung cancer. @ASCO @WinshipAtEmory

Conquer Cancer, the ASCO Foundation

@ConquerCancerFd

5 months

We are proud to share that @RamalingamMD , a 2006 Conquer Cancer Career Development Award recipient, was met with a standing ovation from the #ASCO24 plenary session crowd as he presented breakthrough results from the phase 3 LAURA study. Learn more @ASCO

2

12

62

2

13

92

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

A tremendous honor to meet Her Royal Highness Princess Dina Mired of Jordan ⁦ @dinamired ⁩ at #WCLC2023 ⁦ @IASLC ⁩. Her speech calling for equity in cancer care is a call to action for all of us. ⁦ @WinshipAtEmory ⁩

0

3

88

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Congrats to recipients of @IASLC Distinguished Awards. L These leaders have inspired progress in lung cancer through decades of excellence. #LCSM #WCLC20 @HwakeleeMD

2

14

88

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

7 years

Excited to learn about FDA approval of osimertinib for 1st line treatment of EGFR MT NSCLC today. @WinshipAtEmory #LCSM @EGFRResisters

2

26

86

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Checkmate 743 demonstrates superiority for Ipi plus nivo over chemo in mesothelioma. Hazard ratio 0.75. @IASLC #VPS20 . A new front line option for meso.

1

19

83

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

I cannot resist saying this today: How about them peaches! #GeorgiaFlipped #GeorgiaSavesDemocracy @wallyjc @JeffBradleyMD @HwakeleeMD @CoreyLangerMD @VamsiVelcheti @montypal

5

0

79

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

I voted this am; to change the political discourse, for a science-driven society, for fairness and justice, for improved gun safety, quality education for all and healthcare for all! Did you vote?

4

8

81

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

Remarkable results from MARS2 study for mesothelioma. No role for surgery in early stage disease. Congrats to the study team from @UK . ⁦ @IASLC ⁩ #wclc23 ⁦ @WinshipAtEmory ⁩

4

24

82

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Lung cancer mortality reducing rapidly in the United States: if only we can increase adoption of CT screening, we can do even better! #LCSM @winshipatEmory Cancer statistics, 2020

1

33

82

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

#RBG ’s death is an immeasurable loss to our country. I can’t stop thinking of the cascade of events that will unfold in the upcoming weeks, none of which are likely good for the future. #vote

1

3

79

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Winston Churchill was opposed to granting independence to India as he believed ‘the Indians cannot be trusted to rule themselves’! How quickly the wheels of history have turned! Happy Diwali! ⁦ @cspramesh ⁩

7

10

77

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

Immense thanks and gratitude to @DrFadloKhuri for his leadership of @JournalCancer for the past 10 years. I am honored and excited to succeed him. He has positioned us extremely well to move the journal to greater heights. @AUB_Lebanon @WinshipAtEmory @EmoryMedicine

ACS Journal Cancer

@JournalCancer

3 years

We cannot thank our Editor-in-Chief @DrFadloKhuri enough for everything he has done to make CANCER the journal it is today. Read Dr. Khuri's moving reflection on the past 10 years as he passes the baton to our incoming Editor-in-Chief @RamalingamMD :

2

10

122

4

9

77

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

Excited to announce that @AdamMarcusPhD will be the new Deputy Director of @WinshipAtEmory . Feel very fortunate to have a scientist and leader of his caliber on this role. @EmoryMedicine @emoryhealthsci @EmoryUniversity

2

5

77

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Proud moment when ⁦ @KamalaHarris ⁩ spoke Tamil last night. Hebrew and Tamil are the two oldest world languages in use, dating back several thousand years. ⁦ @TamilTechOffici ⁩ #tamil

Family is ‘my chittis’: Kamala Harris puts her Tamil roots on the prime-time stage like never before

The Tamil term of endearment, used for the younger sisters of one’s mother, was a small but significant way for Harris to acknowledge her family's ethnicity.

www.washingtonpost.com

2

4

74

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

7 years

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer — NEJM

4

35

70

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

35% mortality for thoracic cancer patients infected with COVID19; @marinagarassino reports from a global registry @AACR virtual meeting. @IASLC . @WinshipAtEmory

1

35

68

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Congrats to @teekayowo ! Bitter sweet to see my long time friend and colleague move to @UPMCHillmanCC , my alma mater. Our shared aspirations will continue to guide continued collaborations. We are proud of you. @WinshipAtEmory @EmoryMedicine

6

4

70

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

Honored to author this article. @WinshipAtEmory @EmoryMedicine

NatureRevClinOncol

@NatRevClinOncol

6 years

The second of our Year in Review articles is this one by Jennifer Carlisle & Suresh Ramalingam: 'LUNG CANCER IN 2018: A banner year for immunotherapy and targeted therapy'

0

18

32

0

20

69

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

Pleasure to welcome @DrewMoghanaki as the newest member of @WinshipAtEmory Thoracic Oncology Team and Radiation Oncology Dept. @WinshipAtEmory @EmoryMedicine .

3

8

67

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

Congrats to @DrFadloKhuri , recipient of @IASLC Joseph Cullen International Award for Excellence in Cancer Prevention/Early Detection Research! @WinshipAtEmory is proud of this great recognition. @AUB_Lebanon @wallyjc

2

15

68

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

Congrats to @DrNabilSaba for being named the Lynne and Howard Halpern Chair in Head and Neck Cancer Research at @WinshipAtEmory @EmoryUniversity @EmoryMedicine @ASCO @NRGonc @eaonc . Well deserved recognition for an outstanding scholar.

7

4

67

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Excited to share our timely review article on RET positive NSCLC, published in @JTOCRR . @iaslc @winshipat Emory #LCSM RET Fusion: Joining the Ranks of Targetable Molecular Drivers in Non-Small Cell Lung Cancer.

RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC

The era of precision medicine has resulted in the identification of a number of genomic alterations that can be targeted with novel therapies. In lung adenocarcinomas, a histology structure that...

www.jtocrr.org

1

24

66

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Results of lung ART trial being presented @myESMO in 2 weeks. Role of RT in resected N2 disease. I can’t wait... #LCSM

LudaBazhenovaMD

@LudaBazhenovaMD

4 years

To my thoracic oncology colleagues. Besides adjuvant chemotherapy and adjuvant osimertinib ( controversy aside), can you think of other breakthroughs in surgically treated disease?

13

4

23

3

10

66

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Virtual ⁦ @AACR ⁩ reception after a very successful virtual meeting; >60,000 registrations and fantastic sessions. Congrats to everyone who made this possible. ⁦ @WinshipAtEmory ⁩

1

2

66

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

This is one of the most exciting studies presented at #ASC019 with direct implications for lung cancer. @IASLC @WinshipAtEmory @AmgenOncology #LCSM

Vamsi Velcheti, MD MBA FASCO

@VamsiVelcheti

5 years

Great early signal w/AMG510 in kRAS G12C... exciting new agent in a difficult to treat/target population. Hope to have an effective targeted therapy option for this population #LCSM #ASCO19

2

32

80

1

27

66

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Thanks to @WinshipAtEmory @wallyjc @EmoryMedicine @emoryhealthcare for the unflinching support. Congrats and thanks to the entire team of the researchers and colleagues that contributed to the Lung SPORE development. We are excited to get started! #LCSM

Winship Cancer Institute of Emory University

@WinshipAtEmory

5 years

Winship Cancer Institute receives a prestigious Lung Cancer SPORE grant from @theNCI that will allow our cancer researchers to develop new approaches for lung cancer patients and improve outcomes. #lungcancer #lcsm

2

16

80

5

3

64

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Much awaited survival results from the FLAURA study! ⁦ @WinshipAtEmory ⁩ #LCSM ⁦ @AstraZeneca ⁩

3

12

64

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Congratulations to @n8pennell and @teekayowo on their election to leadership roles in @ASCO ! @WinshipAtEmory @ClevelandClinic #LCSM

3

63

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Honored to speak at the 2022 Jane Cook Wright MD Symposium at the #NMAATL2022 meeting in Atlanta today along with ⁦ @NCIDirector ⁩ and ⁦ @EdithMitchellMD ⁩. ⁦ @WinshipAtEmory ⁩ ⁦ @theNCI ⁩ ⁦ @EmoryUniversity ⁩

2

5

61

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Immensely thankful for the incredible @WinshipAtEmory teams that pulled off a @theNCI CCSG site visit and EPIC go-live the same week! Team work at its best! @emoryhealthcare @EmoryUniversity

5

7

63

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

More good news for the lung cancer field- FDA approves Nivo plus Ipi for 1st line treatment of advanced NSCLC. Another effective option to improve survival . @bmsnews @IASLC @WinshipAtEmory #LCSM

0

10

61

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Me: admitting diagnosis: abundance of caution. Insurance company: you must be kidding! @PatelOncology @n8pennell

6

10

61

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

While an excellent #TTLC19 comes to close, the fight against lung cancer continues... thx to all speakers, participants and @IASLC staff. Thanks @OurSantaMonica @WinshipAtEmory @DrRoyHerbstYale @wallyjc . See you back in 2020.

2

11

58

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

My sincere thanks to women physicians @WinshipAtEmory , @EmoryMedicine and beyond for their hard work and dedication to improving the lives of our patients on the occasion of National Women Physicians Day.

1

5

58

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 months

Great to see lung cancer research highly represented at the @ASCO plenary session. This has been a long time coming! #LCSM @WinshipAtEmory .

Hidehito HORINOUCHI

@HHorinouchi

6 months

⏰NOW OUT‼️ #ASCO24 🔥Plenary Session #LCSM ✅ #LBA3 Early palliative care via telehealth vs in person 🎙️Dr.Joseph Greer ✅ #LBA4 LAURA: Osi after CRT in EGFRm 🎙️ @RamalingamMD ✅ #LBA5 ADRIATIC: Durva after CRT in ES-SCLC 🎙️ @DavidRSpigel @OncoAlert @ASCO

0

6

21

2

10

57

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

⁦ @reshmajagsi ⁩ speaking at her welcome reception to ⁦ @EmoryUniversity ⁩ and ⁦ @WinshipAtEmory ⁩. We are excited to have you here.

1

8

57

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

No doubt @harpreet_md has had a busy several months reviewing all the applications that resulted in multiple FDA approvals for lung cancer. Thank you from the entire lung cancer community and our patients. @WinshipAtEmory #LCSM @IASLC

Harpreet Singh, MD

@harpreet_md

4 years

Today, FDA approved nivolumab + ipilimumab & 2 cycles of chemotherapy for metastatic NSCLC based on the 9LA study. ✅ Part of OCE’s Project ORBIS ✅ reviewed with HC, TGA, HSA 2️⃣ months ahead of FDA goal . @FDAOncology

5

19

63

3

10

55

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Will miss the sights and sounds in Vienna, but certainly not the science, thanks to virtual @IASLC and tweets from @StephenVLiu @HwakeleeMD @LealTiciana @KHigginsMD . #WCLC22 @WinshipAtEmory

3

1

54

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

11 months

Looking forward to the exciting presentations at ⁦ @WinshipAtEmory ⁩ Annual Scientific Symposium today. Keynote lecture by Dr. Carl June. #where science becomes hope. ⁦ @AdamMarcusPhD ⁩ ⁦ @LesinskiLab ⁩ ⁦ @EmoryUniversity ⁩

0

7

56

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

⁦ @AdamMarcusPhD ⁩ honored as a Winship 5K Professor today! A great event to honor an innovative scientist, leader and friend. ⁦ @WinshipAtEmory ⁩ ⁦ @EmoryUniversity ⁩ ⁦ @emoryhealthsci ⁩ ⁦ @wallyjc ⁩

5

4

55

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Congrats to ⁦ @WinshipAtEmory ⁩ honorees at ⁦ @ConquerCancerFd ⁩ ceremony at #ASCO22 . ⁦ @MylinTorres ⁩ ⁦ @ASCO ⁩ ⁦ @EmoryUniversity ⁩

0

4

54

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

After concurrent therapy, this is the first major advance in stage 3 NSCLC. Improved survival firms up the role of Durvalumab in this setting. @WinshipAtEmory #LCSM @AstraZeneca

Imfinzi significantly improves overall survival in the Phase III PACIFIC trial for unresectable...

www.astrazeneca.com

1

27

55

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Congrats to @christine_lovly , on recognition as the ECOG-ACRIN Young Investigator Award @eaonc . This award recognizes her outstanding contributions to thoracic oncology. @VUMC_Cancer @NCICTEP_ClinRes #LCSM @HwakeleeMD

1

54

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

⁦ @IASLC ⁩ virtual board meeting this am; great to connect with colleagues from across the world. ⁦ @HwakeleeMD ⁩ ⁦ @giorgioscaglio3 ⁩ ⁦ @DrRoyHerbstYale ⁩ ⁦ @CBelaniMD ⁩

1

3

53

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

Checkpoint inhibition has 24% RR in BRAF mutated NSCLC- this is the best among various driver mutation groups. #ASCO18 @WinshipAtEmory #LCSM presentation by Dr. Mazieres.

1

23

53

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

One for the history books! What a come back from 36 all out! vs Australia ⁦ @cspramesh ⁩ ⁦ @HaydnKissick ⁩ ⁦ @BCCI ⁩ @VamsiVelcheti ⁩ ⁦ @DrSanjayPopat ⁩ ⁦ @neerajaiims ⁩ ⁦ @MichaelBoyer1 ⁩

India vs Australia: Indomitable India breach Aussie fortress to win series 2-1 and rewrite history...

Cricket News: Words are not enough to describe just what Team India have pulled off in Brisbane. Imagine this - the Gabba in Brisbane is a venue where Australia had

timesofindia.indiatimes.com

3

6

52

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 months

Great to spend a few precious minutes with the ⁦ @NIHDirector ⁩ ⁦ @ASCO ⁩ along with fellow ⁦ @WinshipAtEmory ⁩ faculty member ⁦ @judywawira ⁩. ⁦ @theNCI ⁩

0

8

53

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

November is Lung Cancer Awareness month! Let us all work together to raise awareness and dispel the nihilism that still exists against lung cancer. ⁦ @jillfeldman4 ⁩ ⁦ @Pattybeatslungc ⁩ ⁦ @WinshipAtEmory ⁩

0

8

53

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

Congratulations to my good friend and colleague @teekayowo on this appointment! @WinshipAtEmory is proud and sends best wishes. @UMGCCC @AACI_Cancer @eaonc

UMGCCC

@UMGCCC

1 year

We are excited to welcome Dr. Taofeek Owonikoko as our new Executive Director. Dr. Owonikoko, an internationally recognized thoracic oncologist who specializes in treating lung cancer, will take over from Dr. Kevin J. Cullen, who has served as Director for the past 20 years!

51

29

283

2

5

53

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 months

Celebrating #National Clinical Trials Day ⁦ @WinshipAtEmory ⁩. Truly takes a village to conduct clinical trials. >240 individuals including virtual staff living in 25 different states make it possible here! My sincere thanks to all trials teams. ⁦ @theNCI ⁩ ⁦⁦

1

4

52

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Congrats to @bilenma for his appointment as the Director of the Genito-Urinary Medical Oncology Group @WinshipAtEmory ! The program is poised to make great strides under your leadership. @EmoryMedicine @emoryhealthsci

4

3

51

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

Thanks to ⁦ @HwakeleeMD ⁩ for leading ⁦ @IASLC ⁩ admirably for the past two years. ⁦ @WinshipAtEmory ⁩ ⁦ @Stanford ⁩ #wclc23

0

5

51

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

Thanks to our amazing main lobby staff at the ⁦ @WinshipAtEmory ⁩ Midtown on day 1 of patient care at our new facility. Every patient in my clinic complemented how pleasant their check in experience was. No lines and no waiting! ⁦ @emoryhealthcare ⁩

1

3

49

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

This exceptional new facility will bring innovative research and outstanding patient care to improve the lives of cancer patients. @WinshipAtEmory @wallyjc @EmoryMedicine @EmoryUniversity

Emory University

@EmoryUniversity

5 years

Emory, @WinshipAtEmory break ground on Midtown Atlanta building designed to put patients at the center of specialized care communities

2

11

52

2

5

49

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

Thanks for the great support from our patients, families, friends, faculty and staff for @Winship5K @WinshipAtEmory this am. #WhereScienceBecomesHope . @EmoryUniversity @gregfenves @AdamMarcusPhD @emoryhealthcare @EmoryMedicine

0

3

49

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

⁦ @LealTiciana ⁩, the newest addition to ⁦ @WinshipAtEmory ⁩ faculty, discusses role of ct DNA testing in lung cancer. #ALCS2021 . #LCSM

3

4

48

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

Honored to serve as co-chair of #TTLC19 with @DrRoyHerbstYale , Paul Bunn and Leora Horn. @WinshipAtEmory @IASLC @giorgioscaglio3

IASLC

@IASLC

6 years

#TTLC19 kicks off in Santa Monica with a packed house for the opening ceremony, including a welcome from IASLC President @giorgioscaglio3

0

3

15

0

4

49

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

With so many @IASLC leaders working on this, I have no doubt that #WCLC19 will be an outstanding success.

IASLC

@IASLC

5 years

The #WCLC19 abstract scheduling session is underway in Barcelona! Nearly 40 of our members have generously donated their weekend to slotting a record number of submitted abstracts into tracks/sessions. We can't thank them enough. It's going to be a great conference! #LCSM

0

12

46

0

8

48

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

We are getting ready for the ⁦ @Winship5K ⁩ (virtual); just a week away. Join us! ⁦ @WinshipAtEmory ⁩ ⁦ @wallyjc ⁩

0

4

48

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

Thanks @HaianFu for your leadership on getting this exciting team science award from @theNCI . Congrats to the entire team. @AdamMarcusPhD @MBeheraPhD @MMG_PhD @MadhavDhodapkar @WinshipAtEmory . @EmoryUniversity

Winship Cancer Institute of Emory University

@WinshipAtEmory

2 years

Winship has been awarded a P01 program project grant from @TheNCI , nearly $11 million over 5 years, to support research aimed at improving the effectiveness of #immunotherapy for #lungcancer in patients. #lcsm ➡️

0

7

50

0

6

47

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

Finally a step forward in SCLC therapy with Atezolizumab plus chemo- HR 0.70 for survival. @IASLC @WinshipAtEmory #WCLC2018 #LCSM

0

18

47

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

Practice changing presentations at the plenary session of World conf in lung cancer. Congrats to ⁦ @IASLC ⁩ #WCLC2018 ⁦ @WinshipAtEmory ⁩ #LCSM

0

13

45

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Thank you ⁦ @SenatorDurbin ⁩ for fighting to keep our children’s safety and health. ⁦ @IASLC ⁩ . Vaping is a major public health threat to our kids

0

21

47

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

6 years

Pembro plus chemo improved OS with 0.62 HR in squamous NSCLC; effect similar with taxol and nab- pac. @WinshipAtEmory #ASC018 #LCSM . Similar HR across different PDL1 exp groups. Will change SOC.

0

30

46

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Excited at be at #ESMO2019 with esteemed colleagues ⁦ @peters_solange ⁩ Dr. Garassino and Dr. Garrido. ⁦ @WinshipAtEmory ⁩

0

5

46

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

Important work to address disparities in health literacy in our patient population. Congrats to the authors. @WinshipAtEmory

ACS Journal Cancer

@JournalCancer

3 years

New study led by @WinshipAtEmory investigators | Short animated videos, which improved patient understanding of chemotherapy terminology in an underserved urban setting, were also successful in significantly improving understanding in a rural setting.

2

7

19

2

6

46

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

Congrats to @AjayNookaMD for his well deserved appointment to this leadership role at @WinshipAtEmory . He brings years of experience, spirit of team work, and excellence in scholarship to this role.

Winship Cancer Institute of Emory University

@WinshipAtEmory

1 year

Winship hematologist Ajay Nooka, MD, MPH, has been named associate director for clinical research, providing strategic oversight for all Winship clinical research with a focus on supporting high-quality, safe and ethical research with equitable access.

13

5

51

1

3

46

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Dilemma in clinic:( Insurance denied MRI brain for lung cancer ptient with brain Mets- requests peer to peer. Should I do it now and have clinic patients waiting or risk missing the call by the time my clinic ends ~6 pm? #lcsm

21

7

46

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

7 years

A new std of care has been defined for adv NSCLC with the results of Keynote 189. Congrats to Dr Leena Gandhi RT al. #AACR2018 #AACR18 @WinshipAtEmory

0

12

43

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Indian cricket has seen many champions - none better than captain @msdhoni ! Thanks for the world championships and everlasting memories! @BCCI @VamsiVelcheti @VivekSubbiah @CharuAggarwalMD @DrSanjayPopat @DrRiyazShah @neerajaiims # via @bcci

MS Dhoni retires from international cricket

www.bcci.tv

2

5

45

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Big thanks to @eaonc staff for their hard work on EA5508 study; special thanks to @SuzDahlberg @mrzebra1 @HwakeleeMD . Together, we have answered in a definitive manner the question about optimal maintenance therapy for NSCLC @WinshipAtEmory #ASC019 #LCSM . @IASLC

2

7

44

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

3 years

Great discussions to reduce cancer burden in Georgia at the virtual summit today. ⁦ @WinshipAtEmory ⁩ ⁦ @ACS_Georgia ⁩ ⁦ @GeorgiaCORE10 ⁩ ⁦ @theNCI ⁩ @thecancer

0

7

43

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

Thank you ⁦ @emoryhealthcare for the efficient, convenient off-campus location and weekend option to get vaccinated. ⁦ @WinshipAtEmory ⁩ ⁦ @EmoryMedicine ⁩

0

1

44

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

4 years

A past president @ASCO and the president-elect! @hoosierdfh

0

1

44

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

1 year

What a milestone for @JournalCancer ! I am honored to serve as the editor in chief of this amazing journal. @WinshipAtEmory @ACS_Research

ACS Journal Cancer

@JournalCancer

1 year

It's our 75th birthday! 📗 🎉 Since 1948, CANCER has been dedicated to bringing the best of science to the broadest audience—always aligned with the @AmericanCancer mission of ending cancer as we know it, for everyone. 🔗 @RamalingamMD #Cancer75

1

7

21

0

4

43

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

7 years

Fun sprinting up 38 flights of stairs with Team EMORY to raise funds for @LungAssociation . @WinshipAtEmory @wallyjc @EmoryMedicine . 2018 Fight for Air.

0

3

43

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5 years

Congrats to @wallyjc for this recognition and honor! His work has changed treatment paradigms for cancer and improved lives of patients the world over. @WinshipAtEmory @EmoryMedicine @emoryhealthcare @ASTRO_org

Winship Cancer Institute of Emory University

@WinshipAtEmory

5 years

At a special ceremony taking place at #ASTRO19 today, Winship Executive Director and Radiation Oncology Chair Walter J. Curran, Jr., MD, will be honored with a 2019 ASTRO Gold Medal for outstanding contributions in the field of radiation oncology. ➡️

2

8

32

0

10

43

Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

2 years

I think the question now shifts to studying chemo plus TKI in ctDNA persistence after 3-6 weeks of TKI therapy. @StephenVLiu

Stephen V Liu, MD

@StephenVLiu

2 years

Are the risks of chemo offset by a PFS gain that does not translate into an OS benefit? How does this frame the results of FLAURA2 (osi +/- chemo), which has a PFS primary endpoint? I would expect RR and PFS to improve - but I think an OS benefit is needed to change the SOC here.

8

4

33

3

7

42